Showing 1 - 20 results of 20 for search 'Ronald J Bosch', query time: 0.07s
Refine Results
-
1
-
2
Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. by Nancie M Archin, Manzoor Cheema, Daniel Parker, Ann Wiegand, Ronald J Bosch, John M Coffin, Joseph Eron, Myron Cohen, David M Margolis
Published 2010-02-01
Article -
3
Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events by Sergio Serrano-Villar, Kunling Wu, Peter W. Hunt, Judith J. Lok, Raquel Ron, Talía Sainz, Santiago Moreno, Steven G. Deeks, Ronald J. Bosch
Published 2022-06-01
Article -
4
Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed... by Brett B. Williams, Stefan J. Green, Ronald J. Bosch, Ellen S. Chan, Jeffrey M. Jacobson, David M. Margolis, Phillip Engen, Alan L. Landay, Cara C. Wilson
Published 2019-09-01
Article -
5
CD4 trajectory adjusting for dropout among HIV‐positive patients receiving combination antiretroviral therapy in an East African HIV care centre by Agnes N Kiragga, Judith J Lok, Beverly S Musick, Ronald J Bosch, Ann Mwangi, Kara K Wools‐Kaloustian, Constantin T Yiannoutsos, for the East Africa IeDEA Regional Consortium
Published 2014-01-01
Article -
6
Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy by Melissa A. Tosiano, Hanna Mar, Dianna Hoeth, Joseph J. Eron, Rajesh T. Gandhi, Deborah K. McMahon, Ronald J. Bosch, John W. Mellors, Joshua C. Cyktor
Published 2022-12-01
Article -
7
HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077. by Rami Kantor, Daniel Bettendorf, Ronald J Bosch, Marita Mann, David Katzenstein, Susan Cu-Uvin, Richard D'Aquila, Lisa Frenkel, Susan Fiscus, Robert Coombs, ACTG A5077 Study Team
Published 2014-01-01
Article -
8
Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption by You Park, Behzad Etemad, Hayat Ahmed, Vivek Naranbhai, Evgenia Aga, Ronald J. Bosch, John W. Mellors, Daniel R. Kuritzkes, Michael Para, Rajesh T. Gandhi, Mary Carrington, Jonathan Z. Li
Published 2017-11-01
Article -
9
Stability of plasma indices of inflammation/coagulation and homeostasis after fatty and non-fatty meals in treated people with HIV by Dominic Dorazio, Douglas W. Kitch, Netanya S. Utay, Bernard J. Macatangay, Alan Landay, Todd Brown, Ronald J. Bosch, Alison L. Pelger, Jane E. Baum, Robert Asaad, Benigno Rodriguez, Michael M. Lederman
Published 2019-01-01
Article -
10
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. by Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, Christina M Lalama, Joshua C Cyktor, Bernard J Macatangay, Charles R Rinaldo, Sharon A Riddler, Evelyn Hogg, Catherine Godfrey, Ann C Collier, Joseph J Eron, John W Mellors, ACTG A5321 Team
Published 2017-04-01
Article -
11
Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial. by Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch, Ellen S. Chan, David M. Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M. Lederman, Nadia Alatrakchi, Jeffrey M. Jacobson, Ann Wiegand, Mary Kearney, John M. Coffin, John W. Mellors, Joseph J. Eron
Published 2011-08-01
Article -
12
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. by Rajesh T Gandhi, Lu Zheng, Ronald J Bosch, Ellen S Chan, David M Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M Lederman, Nadia Alatrakchi, Jeffrey M Jacobson, Ann Wiegand, Mary Kearney, John M Coffin, John W Mellors, Joseph J Eron, AIDS Clinical Trials Group A5244 team
Published 2010-08-01
Article -
13
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size. by Daniel I S Rosenbloom, Peter Bacchetti, Mars Stone, Xutao Deng, Ronald J Bosch, Douglas D Richman, Janet D Siliciano, John W Mellors, Steven G Deeks, Roger G Ptak, Rebecca Hoh, Sheila M Keating, Melanie Dimapasoc, Marta Massanella, Jun Lai, Michele D Sobolewski, Deanna A Kulpa, Michael P Busch, Reservoir Assay Validation and Evaluation Network (RAVEN) Study Group
Published 2019-04-01
Article -
14
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. by Susanne Eriksson, Erin H Graf, Viktor Dahl, Matthew C Strain, Steven A Yukl, Elena S Lysenko, Ronald J Bosch, Jun Lai, Stanley Chioma, Fatemeh Emad, Mohamed Abdel-Mohsen, Rebecca Hoh, Frederick Hecht, Peter Hunt, Ma Somsouk, Joseph Wong, Rowena Johnston, Robert F Siliciano, Douglas D Richman, Una O'Doherty, Sarah Palmer, Steven G Deeks, Janet D Siliciano
Published 2013-02-01
Article -
15
Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection by Raynell Lang, Elizabeth Humes, Brenna Hogan, Jennifer Lee, Ralph D'Agostino, Joseph Massaro, Arthur Kim, James B. Meigs, Leila Borowsky, Wei He, Asya Lyass, David Cheng, H. Nina Kim, Marina B. Klein, Edward R. Cachay, Ronald J. Bosch, M. John Gill, Michael J. Silverberg, Jennifer E. Thorne, Kathleen McGinnis, Michael A. Horberg, Timothy R. Sterling, Virginia A. Triant, Keri N. Althoff
Published 2022-10-01
Article -
16
The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells by Dennis C. Copertino Jr., Carissa S. Holmberg, Jared Weiler, Adam R. Ward, J. Natalie Howard, Callie Levinger, Alina P.S. Pang, Michael J. Corley, Friederike Dündar, Paul Zumbo, Doron Betel, Rajesh T. Gandhi, Deborah K. McMahon, Ronald J. Bosch, Noemi Linden, Bernard J. Macatangay, Joshua C. Cyktor, Joseph J. Eron, John W. Mellors, Colin Kovacs, Erika Benko, Alberto Bosque, R. Brad Jones, for the AIDS Clinical Trials Group (ACTG) A5321 Team
Published 2023-09-01
Article -
17
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy by Eva M. Stevenson, Adam R. Ward, Ronald Truong, Allison S. Thomas, Szu-Han Huang, Thomas R. Dilling, Sandra Terry, John K. Bui, Talia M. Mota, Ali Danesh, Guinevere Q. Lee, Andrea Gramatica, Pragya Khadka, Winiffer D. Conce Alberto, Rajesh T. Gandhi, Deborah K. McMahon, Christina M. Lalama, Ronald J. Bosch, Bernard Macatangay, Joshua C. Cyktor, Joseph J. Eron, John W. Mellors, R. Brad Jones, for the AIDS Clinical Trials Group A5321 Team
Published 2021-02-01
Article -
18
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective... by Jesper D. Gunst, Jesal Gohil, Johanthan Z. Li, Ronald J. Bosch, Andrea White, Catherine Seamon, Tae-Wook Chun, Beatriz Mothe, Kathleen Gittens, Lauren Praiss, Marie-Angélique De Scheerder, Linos Vandekerckhove, Kevin Escandón, Ann Thorkelson, Timothy Schacker, Devi SenGupta, Christian Brander, Emmanouil Papasavvas, Luis J. Montaner, Javier Martinez-Picado, Ruxandra Calin, Antonella Castagna, Camilla Muccini, Wesley de Jong, Lorna Leal, Felipe Garcia, Rob A. Gruters, Timothy Tipoe, John Frater, Ole S. Søgaard, Sarah Fidler
Published 2025-01-01
Article -
19
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. by Hasina Samji, Angela Cescon, Robert S Hogg, Sharada P Modur, Keri N Althoff, Kate Buchacz, Ann N Burchell, Mardge Cohen, Kelly A Gebo, M John Gill, Amy Justice, Gregory Kirk, Marina B Klein, P Todd Korthuis, Jeff Martin, Sonia Napravnik, Sean B Rourke, Timothy R Sterling, Michael J Silverberg, Stephen Deeks, Lisa P Jacobson, Ronald J Bosch, Mari M Kitahata, James J Goedert, Richard Moore, Stephen J Gange, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA
Published 2013-01-01
Article -
20
Recommendations on data sharing in HIV drug resistance research. by Seth C Inzaule, Mark J Siedner, Susan J Little, Santiago Avila-Rios, Alisen Ayitewala, Ronald J Bosch, Vincent Calvez, Francesca Ceccherini-Silberstein, Charlotte Charpentier, Diane Descamps, Susan H Eshleman, Joseph Fokam, Lisa M Frenkel, Ravindra K Gupta, John P A Ioannidis, Pontiano Kaleebu, Rami Kantor, Seble G Kassaye, Sergei L Kosakovsky Pond, Vinie Kouamou, Roger D Kouyos, Daniel R Kuritzkes, Richard Lessells, Anne-Genevieve Marcelin, Lawrence Mbuagbaw, Brian Minalga, Nicaise Ndembi, Richard A Neher, Roger Paredes, Deenan Pillay, Elliot G Raizes, Soo-Yon Rhee, Douglas D Richman, Kiat Ruxrungtham, Pardis C Sabeti, Jonathan M Schapiro, Sunee Sirivichayakul, Kim Steegen, Wataru Sugiura, Gert U van Zyl, Anne-Mieke Vandamme, Annemarie M J Wensing, Joel O Wertheim, Huldrych F Gunthard, Michael R Jordan, Robert W Shafer
Published 2023-09-01
Article